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Conclusion: Administration of an additional HB is feasible, 
safe and well tolerated in terms of acute and short-term late 
skin and subcutaneous toxicity even though it seems to have 
a role in the edema occurrence. Although G2 dermatitis 
occurred in 16.47% of pts receiving HB vs 7.04% not receiving 
it, the difference was not significant, probably due to few 
observed events. Long term follow up data and a larger 
sample size are needed to confirm these data, assess late 
toxicity and clinical outcomes. 
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Purpose or Objective: The aim of this study was to compare 
the volumes obtained with surgical clips during breast 
conserving surgery of breast cancer patients with volume 
determined using FDG positive tumor volumes outlined in 
pre-operative PET-CT imaging and find out the deviations 
that arise. 
 
Material and Methods: For initial diagnostic PET-CT 
requested by the surgeon, the patients were positioned on 
the breast board with the arm on the ipsilateral side up. 
Those without metastatic tumors and applicable for breast 
conserving surgery went under operation in compliance with 
oncoplastic surgery principles. 4 clips were placed at the 
tumor lodge. For 15 of the patients, before continuing with 
further therapy, the tumor volume outlined with the surgical 
clips and that contoured using the area with FDG affinity 
viewed on the PET-CT were determined. Results were 
statistically analyzed with SPSS software. 
 
Results: This study determined that methods used in 
oncoplastic surgery (such as flap shifting) resulted in 
displacements of the tumors from their original locations. For 
statistics we apply paired t test to the results that we have 
from these different techniques and found the values 
respectively for x,y,z as 0.929, 0.119, 0.991. Even the p 
value that we found is higher than 0.05 and not seems to be 
significant when we evaluate the center of mass deviation 
that we measure with these two techniques makes us to have 
an impact in overall results. 
 
Conclusion: Determination of boost volume using pre-op 
tumor volume is not trustable in cases where tumor volume is 
not marked using clips during oncoplastic surgery of breast 
cancer and may result in geographical misses. 
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Purpose or Objective: To investigate the association 
between the molecular sub-types and the pattern of distant 
metastasis in carcinoma breast. 
 
Material and Methods: 400 patients of locally advanced 
breast carcinoma, without any distant metastasis, both 
clinically or by imaging were studied retrospectively.(Jan 
2010- Dec 2011) The ER/ PR and HER-2neu status of the 
patients was noted and the patients were classified into 
luminal A/B, Triple negative, Her2/neu enriched and 
Luminal/Her. 
All patients had received the treatment for carcinoma breast 
as per the standard protocols i.e. Cuarative treatment with 
surgery, Chemotherapy, and radiotherapy followed by 
hormonal therapy as per the indications. 
All the patients were followed up for local as well as distant 
failure and pattern of failure was co-related with the 
molecular subtypes. 
The major sites of distant metastasis were lungs, liver, bones 
and brain. 
molecular subtypes bone Liver Lungs brain local recurrence 
Luminal A/B 16/30  10/30 2/30 6/30 4/30 
Her 2 Neu enriched 28/66 30/66 20/66 20/56 18/56 
Luminal Her 16/28  11/28 2/28 8/28 6/28 
Triple Negative 7/19 6/19 7/19 4/19 0/19 
       
Results: Brain was the most common site of metastasis in Her 
2 /neu enriched subtype. 
Bone is the most common site of metastasis in all subtypes 
 
Conclusion: A strong association of different metastatic sites 
with the molecular status suggests vigilance about the 
symptoms (metastatic) beforehand. Organ specific metastasis 
may depend on the molecular subtype of the cancer. High 
rate of bone metastasis might be due to the role of bone 
marrow as a homing organ for the cancer cells. Early 
treatment of Her-2/ neu patients withTrastuzumab might 
reduce the rate of metastasis. Tailored strategies against 
distant metastasis concerning the molecular subtypes in 
breast cancer may be considered. 
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Purpose or Objective: Worldwide, breast cancer is the most 
common invasive cancer in women. The management of 
breast cancer depends on multiple factors. The purpose of 
this work is review the currently management of the axilla 
after neoadjuvant systemic therapy in breast cancer 
especially from the point of view of an oncology 
radiotherapist 
 
Material and Methods: In May 2015, we searched clinical trial 
registers, the Cochrane Central Register of Controlled Trials, 
Web of Science, EMBASE and MEDLINE and reviewed 
reference lists. Further hand searches were conducted of 
relevant journal proceedings. At the end, we principally 
reviewed both meta-analyses regarding the results of the SNB 
following NAC in patients with a diagnosis of clinically 
negative axillae, the results of NSABPB-18 and NSABP B-27 
